Takashi Fujiwara

Takashi Fujiwara

Auto-generated profile, based on publicly available information

Takashi Fujiwara

Department of Anaesthesiology, Hyogo Prefectural Kobe Children's Hospital, Kobe, Japan

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 May 2025 in BJA Open
Verified
Journal Article
Open access
SOSoichiro Obara
Soichiro Obara
TKTaiki Kojima
Taiki Kojima
YYYusuke Yamauchi
Yusuke Yamauchi
TFTakashi Fujiwara
Takashi Fujiwara
ASAya Sueda
Aya Sueda
RTRiku Takahashi
Riku Takahashi
Postoperative vomiting (POV) after paediatric strabismus surgery poses both clinical and economic challenges. This study evaluates the cost-effectiveness of different anaesthesia regimens, focusing on the addition of ondansetron (OND), in preventing POV. A cost-effectiveness analysis was conducted from the perspective of a Japanese public healthcare payer using retrospective cohort data of children (aged 3–15 years) undergoing strabismus surgery at three institutions (February 2016–November 2023). The primary outcome measure was cost per averted POV (aPOV) within 24 hours post-surgery. Incremental cost-effectiveness ratios were calculated, and sensitivity analyses accounted for uncertainties. A total of 2772 patients were included. Total intravenous anaesthesia (TIVA) regimens were compared, as OND was used only in TIVA regimens. The aPOV rate for TIVA with sub-Tenon block and dexamethasone (DEX) was 91.0%, whereas TIVA with sub-Tenon block, DEX, and OND had an aPOV rate of 96.3%. The incremental cost of adding OND was €21.2, resulting in an incremental cost-effectiveness ratio of €400.6 per aPOV. A sensitivity analysis showed OND cost was the most influential factor. The cost-effectiveness acceptability frontier showed the probability of cost-effectiveness for TIVA+DEX ranged from 0% to 97.4% for thresholds of €0–€200 per aPOV, whereas TIVA+DEX+OND raged from 0% to 9.3%, and TIVA only ranged from 100% to 0%. TIVA with DEX alone is the most cost-effective regimen for preventing POV in paediatric strabismus surgery in the current Japanese public healthcare system. The addition of OND in TIVA regimens may not be justified from the viewpoint of cost-effectiveness.

16 March 2023 in Pediatric Anesthesia
Verified
Journal Article
Closed access
TFTakashi Fujiwara
Takashi Fujiwara
TKTetsuro Kagawa
Tetsuro Kagawa